뉴스
- Kolon TissueGene Escapes Fourth Limit-Down; Peptron Jumps After Hours[K-Bio Pulse] South Korea’s biotech sector showed sharp divergence on July 24. Kolon TissueGene narrowly avoided a fourth consecutive limit-down close, while Peptron su
- Remedi Surges, HLB Hits Limit Down as FDA Blow Weighs[K-Bio Pulse] The Korean biotech sector saw sharply diverging performances on July 13, with newly listed Remedi. emerging as the day's standout performer, while HLB extended
